Free Trial
OTC:FIZN

First Citizens Bancshares (FIZN) Stock Price, News & Analysis

First Citizens Bancshares logo
$69.40 +0.35 (+0.51%)
As of 10/10/2025

About First Citizens Bancshares Stock (OTC:FIZN)

Advanced

Key Stats

Today's Range
$69.40
$69.40
50-Day Range
$69.05
$69.40
52-Week Range
$52.65
$69.75
Volume
N/A
Average Volume
450 shs
Market Capitalization
N/A
P/E Ratio
19.51
Dividend Yield
0.65%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FIZN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Citizens Bancshares and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FIZN Stock News Headlines

First Citizens to acquire 138 BMO branches
Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
See More Headlines

FIZN Stock Analysis - Frequently Asked Questions

First Citizens Bancshares' stock was trading at $54.05 at the beginning of the year. Since then, FIZN stock has increased by 28.4% and is now trading at $69.40.

Shares of FIZN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Record date for 9/15 Dividend
8/29/2025
Dividend Payable
9/15/2025
Today
10/16/2025

Industry, Sector and Symbol

Stock Exchange
OTC
Industry
Banks - Regional
Sub-Industry
N/A
Current Symbol
OTC:FIZN
CIK
N/A
Fax
N/A
Employees
348
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
19.51
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (OTC:FIZN) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners